Researchers have developed a new way to study bone disorders and bone growth, using stem cells from patients afflicted with a rare, genetic bone disease.
January 07, 2014
December 17, 2013
A team led by scientists from UCSF has discovered that recurrent gliomas may have genetic profiles that are markedly different from those of the initial tumors that spawned them.
December 10, 2013
The day after the 2014 Breakthrough Prize in Life Sciences winners are announced, the recipients – along with 2013 recipients, UCSF Nobel laureates and other luminaries in the field – will participate in a symposium on the state of research in cancer, genetics, neurobiology and stem cells.
August 12, 2013
An international study on epilepsy has uncovered 25 new mutations on nine key genes that could pave the way to develop precise therapies for a devastating form of the disorder during childhood.
July 02, 2013
A UCSF-led team has discovered that vitamin C affects whether genes are switched on or off inside mouse stem cells, suggesting that it may play fundamental role in helping to guide normal development.
June 27, 2013
A new UCSF study highlights the potential importance of the vast majority of human DNA that lies outside of genes within the cell.
May 03, 2013
The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to new research led by scientists at UC San Francisco (UCSF).
May 01, 2013
A UCSF-led research team has identified a genetic mutation that is strongly associated with a typical form of migraine. The discovery could lead to more effective therapies for people with this condition.
April 16, 2013
A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.
April 03, 2013
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers who have outlined their vision of cell-based therapeutics as a “third pillar of medicine."